Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 4 | 2001 | 123 | 0.530 |
Why?
|
| Intensive Care, Neonatal | 3 | 2001 | 38 | 0.330 |
Why?
|
| Infant, Newborn | 13 | 2002 | 2455 | 0.290 |
Why?
|
| Kernicterus | 1 | 2002 | 7 | 0.210 |
Why?
|
| Jaundice, Neonatal | 1 | 2002 | 8 | 0.210 |
Why?
|
| Patient Care Planning | 1 | 2002 | 108 | 0.200 |
Why?
|
| Blood Gas Analysis | 1 | 2002 | 41 | 0.200 |
Why?
|
| Transportation of Patients | 1 | 2002 | 46 | 0.200 |
Why?
|
| Infant, Low Birth Weight | 1 | 2002 | 84 | 0.200 |
Why?
|
| Blood Chemical Analysis | 1 | 2002 | 43 | 0.200 |
Why?
|
| Hypoglycemia | 1 | 2002 | 72 | 0.200 |
Why?
|
| Hospitals, University | 1 | 2002 | 169 | 0.190 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2002 | 101 | 0.190 |
Why?
|
| Hospitals, Pediatric | 1 | 2002 | 114 | 0.190 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2001 | 46 | 0.190 |
Why?
|
| Point-of-Care Systems | 1 | 2002 | 115 | 0.180 |
Why?
|
| Patient Discharge | 1 | 2002 | 294 | 0.170 |
Why?
|
| Critical Care | 1 | 2002 | 263 | 0.170 |
Why?
|
| Down Syndrome | 1 | 2001 | 120 | 0.170 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 1999 | 2 | 0.170 |
Why?
|
| Pediatrics | 1 | 2002 | 341 | 0.160 |
Why?
|
| Pneumonectomy | 1 | 1999 | 79 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 1 | 1999 | 232 | 0.130 |
Why?
|
| Mycoses | 1 | 1996 | 60 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 1996 | 163 | 0.120 |
Why?
|
| Paralysis | 2 | 1995 | 35 | 0.110 |
Why?
|
| Neonatology | 2 | 2002 | 29 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 1999 | 1615 | 0.090 |
Why?
|
| Sudden Infant Death | 1 | 1989 | 6 | 0.090 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 1988 | 11 | 0.080 |
Why?
|
| Humans | 14 | 2002 | 68618 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 1988 | 190 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 1989 | 232 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 1989 | 286 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 1989 | 498 | 0.060 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2002 | 10 | 0.050 |
Why?
|
| Infant Care | 1 | 2002 | 31 | 0.050 |
Why?
|
| Hematocrit | 1 | 2002 | 70 | 0.050 |
Why?
|
| Emergencies | 1 | 2002 | 107 | 0.050 |
Why?
|
| Infant | 3 | 2002 | 2891 | 0.050 |
Why?
|
| Fetus | 1 | 2002 | 157 | 0.050 |
Why?
|
| Physician's Role | 1 | 2002 | 116 | 0.050 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2001 | 15 | 0.050 |
Why?
|
| Retinopathy of Prematurity | 1 | 2001 | 34 | 0.050 |
Why?
|
| Critical Illness | 1 | 2002 | 191 | 0.050 |
Why?
|
| Glucose | 1 | 2002 | 307 | 0.050 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2001 | 69 | 0.040 |
Why?
|
| Equipment Design | 1 | 2002 | 500 | 0.040 |
Why?
|
| Genotype | 1 | 2002 | 786 | 0.040 |
Why?
|
| Anemia | 1 | 2001 | 104 | 0.040 |
Why?
|
| Hypertension | 1 | 1989 | 1535 | 0.040 |
Why?
|
| Parents | 1 | 2002 | 312 | 0.040 |
Why?
|
| Risk Factors | 3 | 2002 | 5731 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2002 | 631 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 772 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 2077 | 0.030 |
Why?
|
| Mass Screening | 1 | 2002 | 843 | 0.030 |
Why?
|
| Prognosis | 1 | 2001 | 2093 | 0.030 |
Why?
|
| Brachial Plexus | 1 | 1995 | 15 | 0.030 |
Why?
|
| Nerve Compression Syndromes | 1 | 1995 | 16 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 51 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 1996 | 384 | 0.030 |
Why?
|
| Regression Analysis | 1 | 1996 | 737 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 1993 | 45 | 0.030 |
Why?
|
| Registries | 1 | 1996 | 733 | 0.030 |
Why?
|
| Swine | 1 | 1993 | 672 | 0.030 |
Why?
|
| Incidence | 1 | 1996 | 1603 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1995 | 375 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1991 | 38 | 0.020 |
Why?
|
| Indomethacin | 1 | 1991 | 107 | 0.020 |
Why?
|
| Time Factors | 1 | 1999 | 4655 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1996 | 2358 | 0.020 |
Why?
|
| Anuria | 1 | 1989 | 3 | 0.020 |
Why?
|
| Hyaline Membrane Disease | 1 | 1989 | 10 | 0.020 |
Why?
|
| Enalapril | 1 | 1989 | 86 | 0.020 |
Why?
|
| Forecasting | 1 | 1989 | 277 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2001 | 7277 | 0.020 |
Why?
|
| Male | 5 | 2001 | 37321 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1989 | 649 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1993 | 2550 | 0.020 |
Why?
|
| Kidney | 1 | 1989 | 945 | 0.010 |
Why?
|
| Pregnancy | 1 | 1989 | 2334 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1989 | 756 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2001 | 205 | 0.010 |
Why?
|
| Logistic Models | 1 | 2001 | 1420 | 0.010 |
Why?
|
| Animals | 1 | 1993 | 20881 | 0.010 |
Why?
|
| Female | 3 | 2001 | 38074 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1995 | 107 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 1140 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1991 | 47 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1991 | 215 | 0.010 |
Why?
|
| Birth Weight | 1 | 1991 | 186 | 0.010 |
Why?
|
| Gestational Age | 1 | 1991 | 389 | 0.010 |
Why?
|
| Linear Models | 1 | 1991 | 521 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1995 | 3259 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1995 | 2223 | 0.000 |
Why?
|